d’Entremont says with 75% net revenue coming from the states, its important the firm makes its stock available to US investors, citing an increase in volume that has likely arisen from upgrading to the OTCQX, the top marketplace where many of the largest OTC companies trade.
Medexus Pharmaceuticals 'becoming very much a US story' with 75% net revenue coming from the states
Quick facts: Medexus Pharmaceuticals Inc
Price: 4.29 CAD
Market Cap: $62.01 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Medexus Pharmaceuticals Inc named herein, including the promotion by the Company of Medexus Pharmaceuticals Inc in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE